Wednesday, 12 November 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 12 November 2025
News

Aussie pharma snags industry exec

Posted 11 November 2025 AM

Fresh from winning a Bronze Stevie with agency partner Pintar Health Connect, Echo Therapeutics has marked another milestone with the appointment of Matthew Ryan to the newly created role of Head of Business Development.

Echo, founded by former Roche high-flyer Jude D'Silva in 2023, has been thriving in a niche market creating new commercial opportunities that reignite established brands and enhance patient outcomes.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (15)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Other (12)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.